Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$14.17
+2.9%
$13.22
$10.45
$21.69
$5.02B0.62799,395 shs362,472 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$91.77
+2.7%
$96.92
$77.10
$163.71
$5.26B0.78965,319 shs984,680 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$166.86
+2.8%
$145.16
$55.92
$168.32
$5.36B1.41477,736 shs851,439 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$0.84
-4.7%
$1.07
$0.59
$4.49
$14.60M3.69174,628 shs98,745 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
+0.67%-5.19%-0.96%+20.91%-11.37%
Glaukos Corporation stock logo
GKOS
Glaukos
+2.70%+1.28%-13.88%-2.36%-26.50%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+1.11%+1.25%+19.43%+15.58%+151.16%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-1.24%-13.82%-11.67%-27.95%-4.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2.8289 of 5 stars
3.11.00.00.02.41.72.5
Glaukos Corporation stock logo
GKOS
Glaukos
3.9931 of 5 stars
3.42.00.04.42.31.70.6
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
1.7856 of 5 stars
2.53.00.00.03.20.80.6
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.3566 of 5 stars
3.55.00.00.04.11.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2.20
Hold$15.569.78% Upside
Glaukos Corporation stock logo
GKOS
Glaukos
2.85
Moderate Buy$127.4238.84% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.00
Buy$157.30-5.73% Downside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00496.66% Upside

Current Analyst Ratings Breakdown

Latest NXL, IRTC, BLCO, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$145.00 ➝ $190.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$139.00 ➝ $170.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$130.00 ➝ $180.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$151.00 ➝ $180.00
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$130.00
7/31/2025
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $16.00
7/31/2025
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$12.00 ➝ $15.00
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/31/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$86.00 ➝ $92.00
(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$4.79B1.05$1.95 per share7.28$18.39 per share0.77
Glaukos Corporation stock logo
GKOS
Glaukos
$383.48M13.72N/AN/A$13.34 per share6.88
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$657.23M8.16N/AN/A$3.23 per share51.66
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$170K85.87N/AN/A$0.34 per share2.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
-$317M-$0.78N/A14.761.35-5.58%2.33%1.12%10/29/2025 (Estimated)
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%N/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$7.61M-$0.76N/AN/A-5,057.14%-209.20%-186.87%8/14/2025 (Estimated)

Latest NXL, IRTC, BLCO, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.14-$0.10+$0.04-$0.10$0.04 million$0.07 million
7/31/2025Q2 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million
7/30/2025Q2 2025
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$0.06$0.07+$0.01-$0.18$1.25 billion$1.28 billion
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 million
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
N/AN/AN/AN/AN/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
0.76
1.55
0.98
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
5.51
4.69
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
6.25
5.02
4.88
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
10.43
10.14

Institutional Ownership

CompanyInstitutional Ownership
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
11.07%
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%

Insider Ownership

CompanyInsider Ownership
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
0.15%
Glaukos Corporation stock logo
GKOS
Glaukos
6.40%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.68%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
25.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
13,500353.99 million353.46 millionOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.35 million53.68 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,00032.13 million31.91 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.42 million13.02 millionNot Optionable

Recent News About These Companies

Nexalin Technology receives IRB approval in Brazil, begins trial
Nexalin completes five phases of virtual clinic, digital research system

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bausch + Lomb stock logo

Bausch + Lomb NYSE:BLCO

$14.17 +0.40 (+2.90%)
Closing price 03:59 PM Eastern
Extended Trading
$14.17 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Glaukos stock logo

Glaukos NYSE:GKOS

$91.77 +2.43 (+2.72%)
Closing price 03:59 PM Eastern
Extended Trading
$91.74 -0.02 (-0.03%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$166.86 +4.51 (+2.78%)
Closing price 04:00 PM Eastern
Extended Trading
$166.86 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$0.84 -0.04 (-4.66%)
Closing price 04:00 PM Eastern
Extended Trading
$0.85 +0.02 (+1.91%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.